GGrantIndex
Sort

85,873 grants matching alzheimers

Core F: Biomarker Core

$1,081,575
Arnold Bakker · Johns Hopkins University · P30 · FY2023 · AG

Tau Protein Aggregation Inhibitors for Tauopathies

$1,081,413
Alan D. Snow · Proteotech, Inc. · R44 · FY2013 · AG

Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer’s Brain Tissue

$1,081,032
Mark Lim · Ambergen, Inc · R44 · FY2023 · AG

Dietary Modification Of Brain Aging And Neurodegenerative Disorders

$1,080,921
Mark P Mattson · National Institute On Aging · Z01 · FY2008 · AG

Neural Mechanisms Underlying Cognitive Contributions to Walking as an Early Marker for Risk of Alzheimer’s Disease and Related Dementias

$1,080,883
Gelsy Torres-Oviedo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG

Cognitive Function, Alzheimer's Disease and Related Disorders in the HAALSI Cohort

$1,080,765
Lisa F Berkman · Harvard School Of Public Health · R01 · FY2018 · AG

Novel Imaging and Biofluid Biomarkers of Small Vessel Cerebrovascular Disease

$1,080,758
Joel H Kramer · University Of California, San Francisco · U01 · FY2023 · NS

Core B - Clinical Core

$1,080,288
Katherine Laurel Possin · University Of California, San Francisco · P30 · FY2024 · AG

SilverBills: A Legal, Technical and Financial Tool for Aging LGBTQ+ Individuals with Impaired Cognition.

$1,080,149
Marci Lobel-Esrig · Silverbills Inc. · R44 · FY2023 · AG

Single-cell epigenomic and trancriptional dissection of sex-specific differences in Alzheimer’s Disease

$1,080,026
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2023 · AG

Boston University Alzheimer's Disease Core Center

$1,079,899
Neil W. Kowall · Boston University Medical Campus · P30 · FY2013 · AG

BDNF Regulation: Roles in Plasticity and Neuroprotection

$1,079,684
Christine M Gall · University Of California-Irvine · P01 · FY2007 · NS

Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease

$1,079,582
Robert W. Mahley · Gabaeron, Inc. · R44 · FY2020 · AG

SIGNAL TRANSDUCTION IN NEURON MIGRATION &AXON GUIDANCE

$1,079,560
Beth Israel Deaconess Medical Center · P01 · FY2003 · NS

BDNF Regulation: Roles in Plasticity and Neuroprotection

$1,079,536
Christine M Gall · University Of California-Irvine · P01 · FY2006 · NS

Leadership in AD/ADRD Drug Discovery

$1,079,483
Stuart A Lipton · Scripps Research Institute, The · R35 · FY2025 · AG

Alzheimer's Disease Patient Registry (ADPR)

$1,079,470
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2008 · AG

Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease

$1,079,457
Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2021 · AG

VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME

$1,079,088
Arthur Dalton · Institute For Basic Res In Dev Disabil · R01 · FY2008 · AG

Whole blood filter paper assay for Alzheimers Disease

$1,078,739
Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2024 · AG

Genetics of Alzheimer's Disease in Israeli Arabs

$1,078,448
Robert Paul Friedland · University Of Louisville · R01 · FY2009 · AG

NovaSeq X Plus Sequencing System

$1,078,438
Peter G Smith · University Of Kansas Medical Center · S10 · FY2024 · OD

Recruitment and Retention Core

$1,078,094
David K Johnson · University Of California At Davis · U19 · FY2021 · NS

Preclinical and early clinical development of a GABA-A a5 PAM

$1,078,000
Kenneth G Payie · Agenebio, Inc. · U01 · FY2025 · AG

Astrocyte and neuron brain-region and compartment-specific proteome dynamics in aging and Alzheimer’s disease

$1,077,865
Baljit Khakh · University Of California Los Angeles · R01 · FY2024 · AG